Introduction: Over the years, heart failure remains one of the most common and prognostically unfavorable conditions. The aim of our study was to determine the frequency of complications in patients with CHF depending on the body weight and intoxication syndrome of varying degrees of severity. Materials and methods: A complete clinical examination was performed in 58 patients (41 (70.6%) men and 17 (29.4%) women) with CHF. In addition to the standard examination in accordance with the protocol, the level of endogenous intoxication was determined by the level of medium-weight molecules (MWM254) and leptin. The patients were randomized into 4 groups depending on their body mass index and the degree of endogenous intoxication. Statistical processing of the results was carried out using the methods of variation statistics “Statistica 6.0”. Results: It was revealed that the worst survival rate is observed in patients with normal body mass against the background of the expressed endogenous intoxication syndrome, the best survival rate is observed provided that there are a normal body mass and endogenous intoxication of a minimum degree. An inverse correlation between the body mass index and the endogenous intoxication indicator (blood MWM) was detected. Patients with CHF should have their leptin level evaluated. An increase in its level was associated with arterial hypertension, an increase in blood glucose levels and lipid metabolism disorders. Conclusions: Increased level of blood MWM worsens the forecast of CHF. The unfavorable outcome was observed in patients with the combination of hypoleptinemia with severe endogenous intoxication.
This article deals with the question of the influence of preparations that contain pharmacological doses of iodine on the functional activity of the thyroid gland. In the practice of a cardiologist amiodarone and x-ray contrasting substances are often used that may induce thyroid disorders in many ways, followed by hypothyroidism and thyrotoxicosis development.
Introduction. Chronic diffuse liver lesions, which is at a certain stage and phase of the disease characterized by excessive accumulation of components of the extracellular matrix, namely fibrosis, – are a heterogeneous multi etiological group of diseases that are characterized by the high prevalence, subclinical course in the initial stages, low curability and reversibility of the pathological process in the late stages, and therefore cause considerable clinical, epidemiological and socio-economic problem of our time. The main way of progression of chronic diffuse liver lesions, regardless of the etiological factor that led to its damage – is the process of fibrogenesis. Quantitative indicators of the severity and rate of fibrosis progression are the most important clinical parameter, the determination of which is crucial for choosing the right treatment and for monitoring its effectiveness. Today, there is no universal method and only a combination of different laboratory and instrumental methods of examination can significantly increase their diagnostic value for early detection of liver fibrosis in the case of chronic diffuse liver diseases. However, the range of possibilities of certain diagnostic methods is constantly expanding and recently the elastographic method has become increasingly important. The aim of the study. To make the literature review concerning the modern principles of liver fibrosis diagnosis in patients with chronic diffuse liver lesions, to describe the clinical case. Materials and methods. The content analysis, method of the system and comparative analysis, the bibliosemantic method of study of the actual scientific studies concerning modern principles of diagnosis of patients with diffuse liver disease, a clinical case is described. Results. The literature review demonstrates the importance and relevance of early and comprehensive diagnosis of chronic diffuse liver disease. Hepatic fibrosis is the basis for portal hypertension, varicose veins, ascites and liver failure. Decompensated cirrhosis is associated with high mortality and the only effective treatment is liver transplantation. Assessment of the degree of liver fibrosis is important for several reasons: to determine the prognosis of chronic liver damage, to select patients for specific (etiotropic) treatment and possible liver transplantation. Therefore, the problem of diagnosis and detection of early initial stages of liver fibrosis for the timely appointment of therapeutic agents, which are aimed at reducing the rate of its progression and prevent cirrhosis and liver cancer, is extremely important for modern medicine. It is known that the “gold standard” for the diagnosis of liver fibrosis is a liver biopsy, but the method has many limitations and contraindications. Elastography is one of the most promising non-invasive methods to diagnose liver fibrosis and steatosis in the case of chronic diffuse liver lesions, which can be used as an alternative to biopsy. Given its widespread implementation in clinical practice, groups of scientists from around the world are paying more and more attention to the study of factors that may affect the results of elastometry and its diagnostic effectiveness. The advantages of the method of liver elastography include: non-invasive, no contraindications, simplicity, fast execution and interpretation; the ability to determine the stage of fibrosis in patients who can not perform a liver biopsy (coagulopathy, thrombocytopenia); the possibility of repeated procedures to assess the increase in severity. Conclusions. Thanks to modern scientific achievements, the latest technologies have been introduced into clinical practice, with the help of which clinicians successfully improve the diagnosis of chronic diffuse liver diseases, in particular, through the use of quantitative detection of fibrotic changes in it, establishing the nature of abdominal fluid (serous or mucinous), assessment of hepatic venous pressure due to safe non-invasive and informative method of shear wave elastography of the liver, a method that not only allows to objectify the verification of the diagnosis, but also to dynamically assess the efficiency of treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.